The EMA’s human medicines committee recommended 114 medicines for approval in 2024, marking the highest number of positive opinions issued in 15 years, according to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
ArriVent Biopharma, a Pennsylvania drugmaker developing a China-approved cancer treatment for the US and other geographies, plans to raise net proceeds of about $135 million
In this video interview, Paul Offit, MD, of Children’s Hospital of Philadelphia, discusses three preventive measures to protect infants from respiratory syncytial virus (RSV) this
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Clinicians Protest ICU Closure at Minnesota